Viewing Study NCT02233712


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2025-12-26 @ 10:46 PM
Study NCT ID: NCT02233712
Status: COMPLETED
Last Update Posted: 2014-09-08
First Post: 2014-08-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer.
Sponsor: Cancer Advances Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module